Annual Immunisation Coverage Report 2017

Abstract

This eleventh national annual immunisation coverage report focuses on data for the calendar year 2017 derived from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register. This is the first report to include data on HPV vaccine course completion in Aboriginal and Torres Strait Islander (Indigenous) adolescents. ‘Fully immunised’ vaccination coverage in 2017 increased at the 12-month assessment age reaching 93.8% in December 2017, and at the 60-month assessment age reaching 94.5%. ‘Fully immunised’ coverage at the 24-month assessment age decreased slightly to 89.8% in December 2017, following amendment in December 2016 to require the fourth DTPa vaccine dose at 18 months. ‘Fully immunised’ coverage at 12 and 60 months of age in Indigenous children reached the highest ever recorded levels of 93.2% and 96.9% in December 2017. Catch-up vaccination activity for the second dose of measles-mumps-rubella-containing vaccine was considerably higher in 2017 for Indigenous compared to non-Indigenous adolescents aged 10–19 years (20.3% vs. 6.4%, respectively, of those who had not previously received that dose). In 2017, 80.2% of females and 75.9% of males aged 15 years had received a full course of three doses of human papillomavirus (HPV) vaccine. Of those who received dose one, 79% and 77% respectively of Indigenous girls and boys aged 15 years in 2017 completed three doses, compared to 91% and 90% of non-Indigenous girls and boys, respectively. A separate future report is planned to present adult AIR data and to assess completeness of reporting.

Closing the vaccination coverage gap in New South Wales: the Aboriginal Immunisation Healthcare Worker Program

“…To allow for late notification of vaccinations, a 3-month lag period was applied; 11 that is, cohort vaccination status was assessed at 9 months of age (for vaccines due at 6 months), 15 months of age (for vaccines due at 12 months), and at 51 months of age (for vaccines due at 48 months). These assessment milestones correspond to those of the NSW AIHCW Program key performance indicators, but are earlier than those usually employed for vaccination coverage reporting in Australia (12, 24, 60 months), 12 placing greater emphasis on the timeliness of vaccination in coverage estimates. The proportions of children classified as fully vaccinated were calculated by dividing the number completely vaccinated at each of the three assessment milestone ages (Box 1) by the total number of Australian Immunisation Register-registered children in their age group.…”

“…Proportion of children at 15 months of age who were fully vaccinated (with 95% confidence intervals), for New South Wales and the rest of Australia, by Indigenous status, 2008e2016facilitated by a change to the overdue rules of the register in January 2009; specifically, children were now deemed overdue for their pre-school boosters at 49 rather than 60 months of age. This change had an impact on eligibility for parental incentive payments and outcome payments for providers 21. …”

Avaliação de coberturas vacinais de crianças em uma cidade de médio porte (Brasil) utilizando registro informatizado de imunização

“…Neste estudo, foram alcançadas altas coberturas, com resultados semelhantes aos encontrados em Curitiba (Paraná) 14 , um grande centro urbano com programa de imunização e RII maduros, porém, em geral, melhores que na maioria das capitais brasileiras 15 , as quais, apesar de também serem grandes centros urbanos, não possuíam RII maduros à época do estudo. Também se observaram coberturas mais altas ou semelhantes às apresentadas em países desenvolvidos, como Estados Unidos e Austrália, porém com menor porcentagem de doses inválidas 6,7,16,17 .…”

Why Infants Rarely Die of COVID-19 and Morbidity and Mortality Rates Vary by Location: Pneumococcal and Hib Vaccinations as Possible Means to Mitigate Future Pandemics

“…* Gervaix, et al, 2014;^ Mereckiene, 2017;+ WHO, 2020;> Blank, et al, 2018; # estimated from accumulated yearly vaccinations. Austria (Richter, et al, 2019); France (Contou, et al, 2020); Germany (Theidel, et al, 2013;Pletz, et al, 2016); Greece (Maraki, et al, 2018);US (FluVaxView;Wateska, et al, 2020;Zhang, et al, 2018;Sings, 2017;Williams, et al, 2016); UK (Tolman, et al, 2016); Australia (Hull, et al, 2019;Yang, et al, 2019;Dyda, et al, 2016); Japan (Naito, et al, 2020;Takeda, et al, 2019;Shibata, et al, 2019;Kajikawa, et al, 2019;Kumar, et al, 2014); S. Korea (Song, et al, 2013;Yang, et al, 2015;Park, et al, 2019;Yang, et al, 2020); Italy (Giammanco, et al, 2018;Baldo, et al, 2016;Tozzi, et al, 2014;Fedson, 2011); Spain (Ciruela, et al, 2018;Arencibia Jiménez, et al, 2014;Fedson, 2011); Canada (Kaplan, et al, 2019;Farmanara, et al, 2018); Portugal (Kislaya, et al, 2019); Netherlands (Vestjens, et al, 2019); Switzerland ** NB no current data available (Büla, et al, 1996). (TABLE 1).…”